180 Life Sciences Corp(NASDAQ:ATNF) 
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibros...
Website: https://180lifesciences.com/
Founded: 2016
CEO: Dr Jim Woody
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.85
H 0.87
L 0.83
C 0.83
V 19,081
10EMA 0.83
20EMA 0.83
60EMA 0.83
120EMA 0.83
250EMA 0.83